Exelixis Inc (EXEL)
33.29
-0.39
(-1.16%)
USD |
NASDAQ |
Dec 20, 16:00
33.29
0.00 (0.00%)
After-Hours: 20:00
Exelixis Total Assets (Quarterly): 2.960B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Merck & Co Inc | 117.53B |
| ADMA Biologics Inc | 390.62M |
| Alnylam Pharmaceuticals Inc | 4.205B |
| Pfizer Inc | 219.48B |
| Sarepta Therapeutics Inc | 3.600B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 684.86M |
| Shareholders Equity (Quarterly) | 2.275B |
| Current Ratio | 3.930 |